
Trade Policy Shifts: Compliance and Cost Strategies for Pharma
*full transcript below In Part 3 of our multi-part interview series, Jason Waite, an international trade expert at Alston & Bird, outlines how proposed sector-specific tariffs on pharmaceutical products could significantly disrupt the United States …